Can a simple test right after surgery predict acromegaly cure?

NCT ID NCT00921609

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study followed 20 adults with acromegaly for one year after pituitary surgery. Researchers measured growth hormone and related substances at several time points to see if early test results could predict whether the disease goes into remission. The goal is to find better ways to assess surgical success sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors predict sooner whether acromegaly surgery was effective, potentially guiding earlier follow-up care.

What could go wrong

This is a small, observational study with only 20 people. It does not test a new treatment, so it won't directly change care until larger studies confirm the findings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACROMEGALY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acromegaly

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cedars-Sinai Medical Center, Pituitary Center

    Los Angeles, California, 90048, United States